121 related articles for article (PubMed ID: 22783442)
1. Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humans.
Bascones-Martínez A; López-Durán M; Cano-Sánchez J; Sánchez-Verde L; Díez-Rodríguez A; Aguirre-Echebarría P; Alvarez-Fernández E; González-Moles MA; Bascones-Ilundain J; Muzio LL; Campo-Trapero J
Oncol Lett; 2012 Jun; 3(6):1319-1325. PubMed ID: 22783442
[TBL] [Abstract][Full Text] [Related]
2. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
3. Cellular senescence in oral cancer and precancer and treatment implications: a review.
Campo-Trapero J; Cano-Sánchez J; Palacios-Sánchez B; Llamas-Martínez S; Lo Muzio L; Bascones-Martínez A
Acta Oncol; 2008; 47(8):1464-74. PubMed ID: 18607883
[TBL] [Abstract][Full Text] [Related]
4. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
7. Expression of Ki-67, Cyclin D1, P53, and P16 in patients with oral leukoplakia and leukoplakia cancerization with spicy diet in Chengdu.
Wan ZX; Zheng ZJ; Huang MC; Chen Y; Yao LH
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):434-440. PubMed ID: 34409799
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study.
Humayun S; Prasad VR
Natl J Maxillofac Surg; 2011 Jan; 2(1):38-46. PubMed ID: 22442608
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study.
Sanguansin S; Kosanwat T; Juengsomjit R; Poomsawat S
Int J Dent; 2021; 2021():4089549. PubMed ID: 34853592
[TBL] [Abstract][Full Text] [Related]
11. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.
Haferkamp S; Tran SL; Becker TM; Scurr LL; Kefford RF; Rizos H
Aging (Albany NY); 2009 May; 1(6):542-56. PubMed ID: 20157537
[TBL] [Abstract][Full Text] [Related]
12. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
Mishra R; Das BR
Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
[TBL] [Abstract][Full Text] [Related]
14. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
15. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa.
Liu SC; Hu Y; Sauter ER; Clapper ML; Chen SY; Lanfranchi HE; Engstrom PF; Klein-Szanto AJ
Anal Quant Cytol Histol; 1999 Apr; 21(2):166-73. PubMed ID: 10560487
[TBL] [Abstract][Full Text] [Related]
16. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.
Kresty LA; Mallery SR; Knobloch TJ; Song H; Lloyd M; Casto BC; Weghorst CM
Cancer Res; 2002 Sep; 62(18):5295-300. PubMed ID: 12234999
[TBL] [Abstract][Full Text] [Related]
17. Alterations of Rb, p16(INK4A) and cyclin D1 in the tumorigenesis of oral squamous cell carcinomas.
Nakahara Y; Shintani S; Mihara M; Kiyota A; Ueyama Y; Matsumura T
Cancer Lett; 2000 Nov; 160(1):3-8. PubMed ID: 11098077
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of CD44 and TGF-B Expression in Oral Carcinogenesis.
Ghazi N; Saghravanian N; Taghi Shakeri M; Jamali M
J Dent (Shiraz); 2021 Mar; 22(1):33-40. PubMed ID: 33681421
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of G1 regulatory proteins in human soft tissue sarcomas.
Yoo J; Park SY; Kang SJ; Shim SI; Kim BK
Arch Pathol Lab Med; 2002 May; 126(5):567-73. PubMed ID: 11958662
[TBL] [Abstract][Full Text] [Related]
20. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
